Literature DB >> 24920796

Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.

Jason Porta1, Joyce Jose1, John T Roehrig2, Carol D Blair3, Richard J Kuhn1, Michael G Rossmann4.   

Abstract

UNLABELLED: Alphaviruses are serious, sometimes lethal human pathogens that belong to the family Togaviridae. The structures of human Venezuelan equine encephalitis virus (VEEV), an alphavirus, in complex with two strongly neutralizing antibody Fab fragments (F5 and 3B4C-4) have been determined using a combination of cryo-electron microscopy and homology modeling. We characterize these monoclonal antibody Fab fragments, which are known to abrogate VEEV infectivity by binding to the E2 (envelope) surface glycoprotein. Both of these antibody Fab fragments cross-link the surface E2 glycoproteins and therefore probably inhibit infectivity by blocking the conformational changes that are required for making the virus fusogenic. The F5 Fab fragment cross-links E2 proteins within one trimeric spike, whereas the 3B4C-4 Fab fragment cross-links E2 proteins from neighboring spikes. Furthermore, F5 probably blocks the receptor-binding site, whereas 3B4C-4 sterically hinders the exposure of the fusion loop at the end of the E2 B-domain. IMPORTANCE: Alphaviral infections are transmitted mainly by mosquitoes. Venezuelan equine encephalitis virus (VEEV) is an alphavirus with a wide distribution across the globe. No effective vaccines exist for alphaviral infections. Therefore, a better understanding of VEEV and its associated neutralizing antibodies will help with the development of effective drugs and vaccines.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920796      PMCID: PMC4136364          DOI: 10.1128/JVI.01286-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus.

Authors:  Don L Gibbons; Marie-Christine Vaney; Alain Roussel; Armelle Vigouroux; Brigid Reilly; Jean Lepault; Margaret Kielian; Félix A Rey
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

2.  Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses.

Authors:  J T Roehrig; A R Hunt; G J Chang; B Sheik; R A Bolin; T F Tsai; D W Trent
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

3.  In vitro mechanisms of monoclonal antibody neutralization of alphaviruses.

Authors:  J T Roehrig; A R Hunt; R M Kinney; J H Mathews
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

4.  Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.

Authors:  J H Mathews; J T Roehrig
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies.

Authors:  J T Roehrig; J W Day; R M Kinney
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

Review 6.  Venezuelan equine encephalitis.

Authors:  Scott C Weaver; Cristina Ferro; Roberto Barrera; Jorge Boshell; Juan-Carlos Navarro
Journal:  Annu Rev Entomol       Date:  2004       Impact factor: 19.686

7.  Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies.

Authors:  J H Mathews; J T Roehrig; D W Trent
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes.

Authors:  T M Woodward; B R Miller; B J Beaty; D W Trent; J T Roehrig
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

9.  The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes.

Authors:  J T Roehrig; J H Mathews
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

10.  Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells.

Authors:  J M Wahlberg; H Garoff
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  25 in total

1.  Genetic Characterization of Northwestern Colombian Chikungunya Virus Strains from the 2014-2015 Epidemic.

Authors:  Juan D Rodas; Tiffany Kautz; Erwin Camacho; Luis Paternina; Hilda Guzmán; Francisco J Díaz; Pedro Blanco; Robert Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

Review 2.  Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.

Authors:  Jing Jin; Graham Simmons
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

3.  Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.

Authors:  Anil Verma; Kaustuv Nayak; Anmol Chandele; Mohit Singla; Vinod H Ratageri; Rakesh Lodha; Sushil Kumar Kabra; Kaja Murali-Krishna; Pratima Ray
Journal:  Arch Virol       Date:  2021-04-27       Impact factor: 2.574

4.  Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.

Authors:  Marcílio Jorge Fumagalli; William Marciel de Souza; Marília Farignoli Romeiro; Michell Charles de Souza Costa; Renata Dezengrini Slhessarenko; Luiz Tadeu Moraes Figueiredo
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

5.  Venezuelan Equine Encephalitis Virus V3526 Vaccine RNA-Dependent RNA Polymerase Mutants Increase Vaccine Safety Through Restricted Tissue Tropism in a Murine Model.

Authors:  Clint A Haines; Rafael K Campos; Sasha R Azar; K Lane Warmbrod; Tiffany F Kautz; Naomi L Forrester; Shannan L Rossi
Journal:  Zoonoses (Burlingt)       Date:  2022-01-13

6.  Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.

Authors:  Lauren E Williamson; Kristen M Reeder; Kevin Bailey; Minh H Tran; Vicky Roy; Mallorie E Fouch; Nurgun Kose; Andrew Trivette; Rachel S Nargi; Emma S Winkler; Arthur S Kim; Christopher Gainza; Jessica Rodriguez; Erica Armstrong; Rachel E Sutton; Joseph Reidy; Robert H Carnahan; W Hayes McDonald; Clara T Schoeder; William B Klimstra; Edgar Davidson; Benjamin J Doranz; Galit Alter; Jens Meiler; Kevin L Schey; Justin G Julander; Michael S Diamond; James E Crowe
Journal:  Cell       Date:  2021-08-19       Impact factor: 66.850

7.  Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission.

Authors:  Jason Porta; Vidya Mangala Prasad; Cheng-I Wang; Wataru Akahata; Lisa F P Ng; Michael G Rossmann
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

8.  Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity.

Authors:  Feng Long; Rachel H Fong; Stephen K Austin; Zhenguo Chen; Thomas Klose; Andrei Fokine; Yue Liu; Jason Porta; Gopal Sapparapu; Wataru Akahata; Benjamin J Doranz; James E Crowe; Michael S Diamond; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

9.  Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.

Authors:  Julie M Fox; Feng Long; Melissa A Edeling; Hueylie Lin; Mareike K S van Duijl-Richter; Rachel H Fong; Kristen M Kahle; Jolanda M Smit; Jing Jin; Graham Simmons; Benjamin J Doranz; James E Crowe; Daved H Fremont; Michael G Rossmann; Michael S Diamond
Journal:  Cell       Date:  2015-11-06       Impact factor: 41.582

10.  Designing multivalent immunogens for alphavirus vaccine optimization.

Authors:  C M Read; Kenneth Plante; Grace Rafael; Shannan L Rossi; Werner Braun; Scott C Weaver; Catherine H Schein
Journal:  Virology       Date:  2021-02-05       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.